Karnataka has administered 81.9% of its allocated Human Papillomavirus (HPV) vaccine doses as of 20 August 2026. Only one AEFI has been reported, making Karnataka one of the safest states in the national rollout.
Key Developments
- State ranks seventh nationally in HPV vaccination coverage.
- Single AEFI reported among >4 lakh doses administered.
- District‑wise coverage varies widely – Vijayanagar at 98.3% down to Dakshina Kannada at 47.6%.
- Remaining stock of 93,501 doses, with the Greater Bengaluru Area holding the largest share.
- Plans to extend vaccination to 15‑year‑old girls after the current campaign.
Important Facts
- Total allocated vials: 5,08,030; administered: 4,15,939.
- Highest district coverage: Vijayanagar – 98.3%.
- Lowest district coverage: Dakshina Kannada – 47.6%.
- Vaccine delivered through Ayushman Arogya Mandir, community health centres, taluk and district hospitals, and government medical colleges.
- State Deputy Director (Immunisation) Ravindranath Meti highlighted the role of awareness drives to counter misconceptions.
Exam Relevance
The programme illustrates several themes important for the UPSC exams:
- Public Health Policy: Implementation of a centrally launched vaccination drive at the state level demonstrates federal‑state coordination (GS1).
- Disease Burden Management: cervical cancer is a major health challenge for Indian women; vaccination is a primary preventive strategy.
- Health Infrastructure: Use of Ayushman Arogya Mandir showcases the role of primary health centres in large‑scale immunisation.
- Vaccine Safety Monitoring: Low AEFI numbers reflect effective pharmacovigilance, a key component of health governance.
- Behavioural Change Communication: Addressing vaccine hesitancy in districts like Dakshina Kannada highlights the importance of community engagement.
Way Forward
To achieve full coverage before the end of August, Karnataka must:
- Intensify awareness campaigns in low‑coverage districts, leveraging local administration and health officials.
- Strengthen AEFI surveillance to maintain public confidence.
- Utilise remaining vaccine stock strategically, prioritising high‑population districts.
- Prepare a proposal for vaccinating 15‑year‑old girls, expanding the age group beyond the current 14‑15‑year cohort.
Successful completion will not only reduce the future burden of cervical cancer but also serve as a model for other preventive health programmes across India.